216 related articles for article (PubMed ID: 24453251)
1. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses.
Naji A; Menier C; Morandi F; Agaugué S; Maki G; Ferretti E; Bruel S; Pistoia V; Carosella ED; Rouas-Freiss N
J Immunol; 2014 Feb; 192(4):1536-46. PubMed ID: 24453251
[TBL] [Abstract][Full Text] [Related]
2. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
3. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
4. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
Front Immunol; 2020; 11():608614. PubMed ID: 33505397
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
[TBL] [Abstract][Full Text] [Related]
7. Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall.
Kato Y; Zaid A; Davey GM; Mueller SN; Nutt SL; Zotos D; Tarlinton DM; Shortman K; Lahoud MH; Heath WR; Caminschi I
J Immunol; 2015 Aug; 195(3):1006-14. PubMed ID: 26101322
[TBL] [Abstract][Full Text] [Related]
8. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naïve B-cell phenotype in human tonsils.
Jackson DE; Gully LM; Henshall TL; Mardell CE; Macardle PJ
Tissue Antigens; 2000 Aug; 56(2):105-16. PubMed ID: 11019910
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.
Ketroussi F; Giuliani M; Bahri R; Azzarone B; Charpentier B; Durrbach A
PLoS One; 2011; 6(8):e22776. PubMed ID: 21887223
[TBL] [Abstract][Full Text] [Related]
10. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
11. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
12. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.
Le Rond S; Azéma C; Krawice-Radanne I; Durrbach A; Guettier C; Carosella ED; Rouas-Freiss N
J Immunol; 2006 Mar; 176(5):3266-76. PubMed ID: 16493088
[TBL] [Abstract][Full Text] [Related]
13. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
14. Germinal centers regulate human Th2 development.
Johansson-Lindbom B; Ingvarsson S; Borrebaeck CA
J Immunol; 2003 Aug; 171(4):1657-66. PubMed ID: 12902463
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
[TBL] [Abstract][Full Text] [Related]
16. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
Liang S; Zhang W; Horuzsko A
Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
[TBL] [Abstract][Full Text] [Related]
17. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
Dietrich J; Cella M; Colonna M
J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
[TBL] [Abstract][Full Text] [Related]
18. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles.
Quigley MF; Gonzalez VD; Granath A; Andersson J; Sandberg JK
Eur J Immunol; 2007 Dec; 37(12):3352-62. PubMed ID: 18000950
[TBL] [Abstract][Full Text] [Related]
19. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]